Prognostic significance of magnetic resonance imaging (MRI) of bone marrow in previously untreated patients with multiple myeloma.

被引：0
|
作者：
Dimopoulos, MA
Moulopoulos, LA
Delasalle, K
Weber, D
Gika, D
Alexanian, R
机构：
[1] Univ Athens, Sch Med, GR-11527 Athens, Greece
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2398
引用
收藏
页码：536A / 536A
页数：1
相关论文
共 50 条
  • [21] Clinical significance of magnetic resonance imaging of bone marrow in patients with leukemia
    Wang, Jun
    Zhang, Xiaohui
    Niu, Jinliang
    Journal of Huazhong University of Science and Technology - Medical Science, 2001, 21 (03): : 242 - 245
  • [22] Survival outcomes of patients receiving thalidomide-dexamethasone for previously untreated multiple myeloma.
    Thomas, Sheeba K.
    Giralt, Sergio A.
    Wang, Michael
    Delasalle, Kay B.
    Gavino, Maria
    Rankin, Kim
    Alexanian, Raymond
    Weber, Donna M.
    BLOOD, 2006, 108 (11) : 1019A - 1019A
  • [23] Clinical Significance of Magnetic Resonance Imaging of Bone Marrow in Patients with Leukemia
    王峻
    张晓晖
    牛金亮
    Journal of Tongji Medical University, 2001, (03) : 242 - 245
  • [24] Allogeneic bone marrow transplantation for multiple myeloma.
    Kulkarni, S
    Powles, R
    Treleaven, J
    Singhal, S
    Sastry, P
    Raje, N
    Tait, D
    Mehta, J
    BLOOD, 1997, 90 (10) : 4497 - 4497
  • [25] Allogeneic bone marrow transplantation in multiple myeloma.
    Gahrton, G
    Tura, S
    Svensson, H
    Ljungman, P
    Bladé, J
    Björkstrand, B
    Cavo, M
    Façon, T
    Gratwohl, A
    Cornelissen, JJ
    De Laurenzi, A
    Van Lint, M
    Michallet, M
    Nikoskelainen, J
    Reiffers, J
    Samson, D
    Schattenberg, A
    Verdonck, L
    Volin, L
    Apperley, J
    BONE MARROW TRANSPLANTATION, 1998, 21 : S204 - S204
  • [26] Allogeneic bone marrow transplantation for multiple myeloma.
    Kulkarni, S
    Powles, R
    Mehta, J
    Raje, N
    Singhal, S
    Horton, C
    Tait, D
    Treleaven, J
    BLOOD, 1998, 92 (10) : 352B - 352B
  • [27] Peripheral blood myeloma cells as a prognostic factor for survival in patients with new, untreated multiple myeloma.
    Witzig, TE
    Gertz, MA
    Lust, JA
    Kyle, RA
    OFallon, WM
    Greipp, PR
    BLOOD, 1995, 86 (10) : 217 - 217
  • [28] The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma
    Ghosh, Toshi
    Gonsalves, Wilson I.
    Jevremovic, Dragan
    Dispenzieri, Angela
    Dingli, David
    Timm, Michael M.
    Morice, William G.
    Kapoor, Prashant
    Kourelis, Taxiarchis V.
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Leung, Nelson
    Go, Ronald S.
    Lin, Yi
    Russell, Stephen J.
    Lust, John A.
    Zeldenrust, Steven R.
    Warsame, Rahma
    Hwa, Yi L.
    Kyle, Robert A.
    Gertz, Morie A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (09) : E507 - E512
  • [29] Prognostic significance of BCL-2 expression in patients with multiple myeloma.
    Hashmi, M
    Kojouri, K
    Yang, J
    Patel, S
    Khan, M
    Sylvester-Kohrt, N
    Kamble, R
    Selby, GB
    Ozer, H
    Kharfan-Dabaja, MA
    BLOOD, 2004, 104 (11) : 292B - 293B
  • [30] Bone marrow imaging of bone marrow transplanted multiple myeloma patients
    Agren, B
    Rudberg, U
    Mare, K
    Aspelin, P
    CLINICAL NUCLEAR MEDICINE, 1997, 22 (02) : 80 - 92
12345